Jul 8, 2026

[8-K Watch] debt and departures

fifteen material 8-Ks filed since yesterday afternoon. seven created direct financial obligations, four involved executive departures or appointments, three preannounced earnings, two completed acquisitions, and a handful of other events. no restatements. no auditor changes. the

fifteen material 8-Ks filed since yesterday afternoon. seven created direct financial obligations, four involved executive departures or appointments, three preannounced earnings, two completed acquisitions, and a handful of other events. no restatements. no auditor changes. the mix is heavy on small-cap biotech and industrial names securing financing.

debt obligations

$HURA, TuHURA Biosciences, Inc./NV. item 2.03: creation of a direct financial obligation. link

$BNZIW, Banzai International, Inc. item 1.01: entry into a material definitive agreement. item 2.01: completion of acquisition or disposition of assets. item 2.03: creation of a direct financial obligation. item 3.02: unregistered sales of equity securities. link

Golub Capital Private Credit Fund, no ticker. item 1.01: entry into a material definitive agreement. item 2.03: creation of a direct financial obligation. link

$POLA, Polar Power, Inc. item 1.01: entry into a material definitive agreement. item 2.03: creation of a direct financial obligation. item 3.02: unregistered sales of equity securities. link

$CDTTW, CDT Equity Inc. item 1.01: entry into a material definitive agreement. item 2.03: creation of a direct financial obligation. link

$CMT, Core Molding Technologies Inc. item 1.01: entry into a material definitive agreement. link

$ELAB, PMGC Holdings Inc. item 1.01: entry into a material definitive agreement. link

executive moves

$CRSF, Crisp Momentum Inc. item 5.02: departure or appointment of directors or officers. link

$TBH, House of Doge Inc. item 2.01: completion of acquisition or disposition of assets. item 3.02: unregistered sales of equity securities. item 5.01: changes in control of registrant. item 5.02: departure or appointment of directors or officers. item 5.03: amendments to articles of incorporation or bylaws. item 8.01: other events. link

$AURA, Aura Biosciences, Inc. item 5.02: departure or appointment of directors or officers. link

$VVOS, Vivos Therapeutics, Inc. item 1.01: entry into a material definitive agreement. item 3.02: unregistered sales of equity securities. item 5.03: amendments to articles of incorporation or bylaws. link

earnings preannouncements

$FGRS, Figure Technology Solutions, Inc. item 2.02: results of operations, earnings preannouncement. link

$RSMDF, RESMED INC. item 2.02: results of operations, earnings preannouncement. link

$SOTK, SONO TEK CORP. item 2.02: results of operations, earnings preannouncement. link

other material events

Keenova Therapeutics plc, no ticker. item 8.01: other events, often regulatory or litigation. link

the pattern is unremarkable but consistent. small and micro-cap companies are layering on debt and issuing equity, often in the same filing. the $TBH filing stands out as the only change-of-control event in the batch, a full corporate reset with new officers, new bylaws, and an acquisition closing all at once. no large-cap names filed material 8-Ks in this window. the market is quiet at the top and busy at the bottom.

more at falsifylab.com


Originally published on FalsifyLab Substack.

— research and educational content. not investment, legal, or tax advice. do your own research. positions and views may change without notice.